Le Lézard
Classified in: Health
Subjects: AWD, TDS

Fresenius Medical Care North America, American Nephrology Nurses Association Announce Recipients of Nursing Educational Scholarships


WALTHAM, Mass., April 18, 2018 /PRNewswire/ -- As part of an ongoing commitment to support nurses dedicated to caring for patients with kidney disease, Fresenius Medical Care North America (FMCNA), the nation's leading renal care company, and the American Nephrology Nurses Association (ANNA) announced five recipients of educational scholarships at ANNA's 2018 National Symposium in Las Vegas.

FMC and ANNA letterhead

The five scholarship recipients were selected out of 32 applicants and will receive $4,000 ahead of the fall 2018 academic year.

The scholarships were made possible through a $20,000 grant from FMCNA provided to ANNA for the education of its members.

"We are thrilled to honor these five inspiring nephrology nurses and students," said Lynda Ball, MSN, RN, CNN, ANNA president. "We thank Fresenius Medical Care North America for their partnership and commitment to furthering education for our nephrology nurses."

"As a leader in renal care, we are committed to recognizing the passion and dedication of nephrology nurses across the country," said Ron Rodgers, Executive Vice President, FMCNA and President, Fresenius Kidney Care. "Congratulations to the scholarship recipients and thank you for the incredible work you do for people living with kidney disease."

Recipients were selected by ANNA based on their academic records, letters of recommendation and essays from each applicant describing their career and educational goals; they include:

The scholarship recipients are also featured on a "Wall of Fame" built specifically for the ANNA National Symposium, the premier nephrology nursing meeting of the year. The three-day event offers opportunities for attendees to expand their knowledge base, enhance their clinical skills and widen their professional network. FMCNA supports ANNA year-round as a Corporate-Plus Member.

For more information on the ANNA-FMCNA partnership and scholarship program, go to https://fmcna.com/about-fresenius-medical-care/responsibility/american-nephrology-nurses-association-partnership/ and https://www.annanurse.org/clinical-practice/award-scholarship-grant-program/2018-anna-scholarship-recipients#fresenius.

About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs, and urgent care centers, as well as the country's largest practice of hospitalist and post-acute providers, Fresenius Medical Care North America provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world's largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com.

About American Nephrology Nurses Association
ANNA is a professional nursing association with more than 8,500 members. ANNA's mission is to improve members' lives through education, advocacy, networking and science.

CONTACT: Rebecca Sail, 1-781-699-9290, [email protected]

SOURCE Fresenius Medical Care North America


These press releases may also interest you

at 11:45
Vertex Pharmaceuticals today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following...

at 11:15
Variantyx, a leader in molecular diagnostics, announced today that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures....

at 11:03
The heart of Vajra Coffee's natural decaffeination process lies in its adoption of the Swiss Water® Process, a natural method that removes 99% of caffeine...

at 11:00
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility,...

at 11:00
United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023,...

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...



News published on and distributed by: